Goeldner, Celia <br/><br/>
Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target.  [electronic resource] 

 -  Neuropharmacology  Jan 2013 
 - 337-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1873-7064 
<br/><br/><label>Standard No.: </label>10.1016/j.neuropharm.2012.08.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antidepressive Agents--adverse effects<br/>Cognition Disorders--chemically induced<br/>Depressive Disorder, Major--drug therapy<br/>Excitatory Amino Acid Agonists--adverse effects<br/>Excitatory Amino Acid Antagonists--pharmacology<br/>GABAergic Neurons--drug effects<br/>Hippocampus--drug effects<br/>Humans<br/>Interneurons--drug effects<br/>Molecular Targeted Therapy<br/>Nerve Tissue Proteins--agonists<br/>Nootropic Agents--pharmacology<br/>Receptors, Metabotropic Glutamate--agonists